Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/EBIT

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/EBIT(x) 23.3527.4720.9934.669.85

What is the latest EV/EBIT ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/EBIT ratio of SYNCOM FORMULATIONS (INDIA) is 23.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202523.35
Mar202427.47
Mar202320.99
Mar202234.66
Mar20179.85

How is EV/EBIT of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/EBIT % Change
Mar2025 23.35
-15.00
Mar2024 27.47
30.87
Mar2023 20.99
-39.44
Mar2022 34.66
251.88
Mar2017 9.85 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/EBIT ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,311.3 Cr 7.3% 12.7% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

7.3%

12.7%

-17.2%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses